Postmarketing Surveillance Crucial for Oncology Agents Safety
Despite the availability of effective cancer therapies, adverse effects may still occur years after treatment. As scientists in the United States highlight, continued vigilance is necessary to monitor side effects, update prescribing information, and alert healthcare providers in a timely manner. Oncology nurses play a vital role in postmarketing surveillance, and incident reporting systems are essential for effective response to changing needs.
Key Takeaways:
- Postmarketing surveillance of oncology agents is crucial for identifying and tracking adverse effects, as these effects may occur more than three decades after drug administration.
- Oncology nurses administer and monitor cancer therapies in outpatient and inpatient settings and are responsible for assessing patients for side effects of therapy.
- Maintaining awareness of short- and long-term adverse effects is vital to patient safety, and nursing leadership should initiate, maintain, and manage incident reporting systems to respond to changing needs.
- Publication of case reports and articles on postmarketing treatment-related side effects in peer-reviewed nursing and medical journals may improve patient care and outcomes.
- The researchers emphasize the importance of continued monitoring of oncology agents to update prescribing information and alert healthcare providers in a timely manner.
Statistics:
- Three decades after drug administration, adverse effects of cancer therapies may still occur according to research.
- The researchers highlighted the importance of postmarketing surveillance for accurately tracking adverse effects of oncology agents.
- The study published in the Clinical Journal of Oncology Nursing found that incident reporting systems are crucial for effective response to changing needs in oncology.
Sources:
- Viale, P.H., et al. "Postmarketing Surveillance for Oncology Drugs." Clinical Journal of Oncology Nursing, vol. 12, no. 6, 2008, pp. 877-886.
- Oncology Nursing Society. 125 Enterprise Dr., Pittsburgh, PA 15275, USA.
- NewsRx.com. Cancer Weekly thanks the University of California's Department of Physiological Nursing for the use of P.H. Viale.